Altamira Therapeutics Ltd. Cash Flows From Used In Investing Activities
Altamira Therapeutics Ltd. (CYTOF) reported Cash Flows From Used In Investing Activities of -$462 for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2025-08-29
CHF
| Period end | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|
| 2023-12-31 | 1.44M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 240.00 CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | -2.14M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | -1.53M CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | -3.51M CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | -1.99M CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | -2.31M CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | -760.86K CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | -3.00M CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | -1.62M CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | -1.82M CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | -19.64K CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | -99.40K CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | -176.77K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | -43.36K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|
| 2025-06-30 | -$462.00 6-K · filed 2025-08-29 | |
| 2024-12-31 | -$115.34K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $621.00 6-K · filed 2025-08-29 | |
| 2023-12-31 | $1.61M 20-F · filed 2025-04-30 | |
| 2023-06-30 | $263.00 6-K · filed 2024-09-24 | |
| 2022-12-31 | -$2.24M 20-F · filed 2025-04-30 |